I dont have issue with using consultants in the space. These guys cant know the global market of BP individuals and manage this carry on here, the day to day, trials etc. The external market is obviously incredibly political, complex and dynamic.
Personally, I think it s a lot for a single consultant firm. If this has been taken on on on contingency, or near so, from a firm that specialises in the function, with no significant connection to BIT otherwise, its imo a good sign.
I keep coming back to the value of incremental advantage in the near term ( a lot more that 17M) and the long term advantage of the novel nature of this tech.... the point they carry on about with the compounds out back... makes this look a whole lot more interesting with an initial success
BIT Price at posting:
1.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)